<DOC>
	<DOCNO>NCT00002595</DOCNO>
	<brief_summary>RATIONALE : Estrogen stimulate growth cancer cell . Hormone therapy use toremifene may fight growth desmoid tumor reduce production estrogen . PURPOSE : Phase II trial study effectiveness toremifene treat patient desmoid tumor .</brief_summary>
	<brief_title>Toremifene Treating Patients With Desmoid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy toremifene term tumor response rate symptom relief patient desmoid tumor . II . Determine safety regimen patient . III . Determine quality life patient treat regimen . OUTLINE : Patients stratify gender . Patients receive oral toremifene daily complete maximal response absence disease progression unacceptable toxicity . Patients achieve maximal response undergo complete resection lesion , feasible . Nonsurgical candidate severe life-threatening disease achieve partial complete response symptom relief 12 month may continue toremifene discretion study chairperson . Patients stable disease undergo surgery may continue toremifene maximum 12 month discretion treat physician . Patients continue experience symptom relief 12 month may continue toremifene discretion study chairperson . Quality life assess baseline 2 6 month . Patients follow every 8 week 4 year annually thereafter . PROJECTED ACCRUAL : A total 24-72 ( 12-36 per stratum ) accrue study .</detailed_description>
	<mesh_term>Fibromatosis , Aggressive</mesh_term>
	<mesh_term>Toremifene</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven primary recurrent desmoid tumor Unresectable symptomatic progressive disease OR Disease mutilating surgery would require complete resection Bidimensionally measurable clinically evaluable disease PATIENT CHARACTERISTICS : Age : 16 ( prepubertal patient ) Performance status : 02 Life expectancy : More 2 month Hematopoietic : Absolute granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 2 mg/dL Transaminases great 3 time upper limit normal ( ULN ) Alkaline phosphatase great 3 time ULN Renal : Not specify Cardiovascular : No history deep vein thrombosis Other : Not pregnant Fertile patient must use effective barrier contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : No concurrent dexamethasone antiemesis No concurrent hormonal therapy , include hormonal contraceptive Radiotherapy : Not specify Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>desmoid tumor</keyword>
</DOC>